1. Insulin and Insulin-Like Growth Factor-1 Associated Cancers
   Sanjay Kumar Dey et al, 2021, Obesity and Cancer CrossRef
2. High Glucose Concentrations Negatively Regulate the IGF1R/Src/ERK Axis through the MicroRNA-9 in Colorectal Cancer
   Ya-Chun Chen et al, 2019, Cells CrossRef
3. Elevated glucose increases genomic instability by inhibiting nucleotide excision repair
   Alexandra K Ciminera et al, 2021, Life Science Alliance CrossRef
4. Diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy
   Anbok Lee et al, 2019, Breast Cancer CrossRef
5. Systems and precision medicine approaches to diabetes heterogeneity: a Big Data perspective
   Enrico Capobianco, 2017, Clinical and Translational Medicine CrossRef
6. A Single-Center Retrospective Chart Review to Determine Whether the Presence of Comorbidities Affects Colon Cancer Screenings in African Americans
   Stacey S. Hodges, 2020, Gastroenterology Nursing CrossRef
7. Insulintherapie bei Diabetes mellitus
   Monika Lechleitner et al, 2016, Wiener klinische Wochenschrift CrossRef
8. Anti-Aging Drugs
   A.M. Vaiserman, 2017, Comprehensive Medicinal Chemistry III CrossRef
9. Association of metabolic syndrome with the risk of developing liver disease in chronic hepatitis B patients
   Julius Dongsogo et al, 2019, African Journal of Biochemistry Research CrossRef
10. BREAST CANCER IN WOMEN WITH DIABETES MELLITUS TYPE 2
    T. S. Vatseba et al, 2019, World of Medicine and Biology CrossRef
11. Activation of the PI3K/AKT/MTOR/P70S6K1 signaling cascade in peripheral blood mononuclear cells in patients with type 2 diabetes
    null null et al, 2020, The Ukrainian Biochemical Journal CrossRef
12. Obesity and diabetes as prognostic factors in patients with colorectal cancer
    Ioannis A. Voutsadakis, 2017, Diabetes & Metabolic Syndrome: Clinical Research & Reviews CrossRef
13. Two Novel Biomarker Candidates for Differentiating Basal Cell Carcinoma from Trichoblastoma; Asprosin and Meteorine Like Peptide
    Nevin Kocaman et al, 2022, Tissue and Cell CrossRef
14. Insulin-like growth factor-1 signaling in renal cell carcinoma
    Adam F. Tracz et al, 2016, BMC Cancer CrossRef
15. Anti-aging pharmacology: Promises and pitfalls
    Alexander M. Vaiserman et al, 2016, Ageing Research Reviews CrossRef
16. Activation of Nrf2 signaling by natural products-can it alleviate diabetes?
    Manuel Matzinger et al, 2018, Biotechnology Advances CrossRef
17. Inhibition of N-methyl-N-nitrosourea-induced gastric tumorigenesis by Liuwei Dihuang Pill in db/db mice
    Shan Zhuang et al, 2017, World Journal of Gastroenterology CrossRef
18. Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis
    Adrian V. Hernandez et al, 2015, European Journal of Cancer CrossRef
19. Recent Findings on Nanotechnology-based Therapeutic Strategies Against Hepatocellular Carcinoma
    Hany A. Abdel Samie et al, 2019, Current Drug Metabolism CrossRef
20. The prognostic outcome of ‘type 2 diabetes mellitus and breast cancer’ association pivots on hypoxia-hyperglycemia axis
    Ilhaam Ayaz Durrani et al, 2021, Cancer Cell International CrossRef
21. Metformin inhibits tumor growth and affects intestinal flora in diabetic tumor-bearing mice
    Jie Kang et al, 2021, European Journal of Pharmacology CrossRef
22. Pleiotropic effects of anti-diabetic drugs: A comprehensive review
    Moumita Nath et al, 2020, European Journal of Pharmacology CrossRef